3,000
Participants
Start Date
January 3, 2023
Primary Completion Date
January 31, 2025
Study Completion Date
December 31, 2027
Buscopan 20 MG/ML Injectable Solution
1 mL intravenously
Sodium bicarbonate
4 g orally
Placebo
4g orally
Nacl 0.9%
1 mL intravenously
RECRUITING
Akershus University Hospital, Lørenskog
RECRUITING
Oslo University Hospital Ullevål, Oslo
RECRUITING
Stavanger University Hospital, Stavanger
RECRUITING
The University Hospital of North Norway, Tromsø
RECRUITING
Oslo University Hospital Rikshospitalet, Oslo
Oslo University Hospital
OTHER